NJADDC Translational Neuroscience Event
Hosted by the New Jersey Academic Drug Discovery Consortium, the Translational Neuroscience Event will feature two panel sessions to discuss "Advances in the Treatment of Alzheimer's Disease" and "CNS Models and Biomarkers."
AGENDA
Session 1: Advances in the Treatment of Alzheimer's Disease
Keynote Speaker |
Samuel Gandy, Mount Sinai Professor of Alzheimer's Disease Research |
Panel Discussion |
Moderator: Mark Day, Adjunct Associate Professor, Neuroscience, Yale University Panelists:
|
Session 2: CNS Models & Biomarkers
Keynote Speaker | Mark Varney, Chief Scientific Officer, PsychoGenics |
Panel Discussion |
Moderator: Sam Kongsamut, Co-founder, Vice President Research & Development, Bryologyx and Strategic Advisor, ILSE Panelists:
|
Brought to you by: Institute for Life Science Entrepreneurship; Rutgers University; Stevens Institute of Technology; Princeton University; Rowan University